A registry for patients with chronic hypoparathyroidism in Russian adults.
hypocalcemia
hypoparathyroidism
parathyroid hormone.
teriparatide (PTH1-34)
Journal
Endocrine connections
ISSN: 2049-3614
Titre abrégé: Endocr Connect
Pays: England
ID NLM: 101598413
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
15
05
2020
accepted:
04
06
2020
pubmed:
25
6
2020
medline:
25
6
2020
entrez:
25
6
2020
Statut:
ppublish
Résumé
Hypoparathyroidism and pseudohypoparathyroidism are rare endocrine disorders, characterized by low serum calcium due to inappropriate parathyroid hormone (PTH) levels or resistance to its action. There is little epidemiological information regarding chronic hypoparathyroidism in Russia. This study aims to build a registry database of Russian patients with chronic hypoparathyroidism who were referred for hospital treatment in order to conduct initial analysis of clinical presentations and hospital management. The Italian registry model was taken to be able to integrate our data in the future. Two hundred patients with hypoparathyroidism (n = 194) and pseudohypoparathyroidism (n = 6) were enrolled over 2 years (2017-2019). The most frequent cause of hypoparathyroidism was neck surgery (82.5%, mostly females), followed by idiopathic hypoparathyroidism (10%), syndromic forms of genetic hypoparathyroidism (4.5%) and forms of defective PTH action (3%). Calcium supplements and alfacalcidol were prescribed in most cases. However, a minority of patients (n = 6) needed to receive teriparatide as the only way to maintain calcium levels and to prevent symptoms of hypocalcemia. Consequently, substitution treatment with parathyroid hormone should be available in certain cases of hypoparathyroidism. This database will be useful to estimate the potential requirement for recombinant PTH in Russia and standards for clinical and therapeutic approaches.
Identifiants
pubmed: 32580149
doi: 10.1530/EC-20-0219
pii: EC-20-0219
pmc: PMC7424359
doi:
pii:
Types de publication
Journal Article
Langues
eng
Pagination
627-636Références
N Engl J Med. 2008 Jul 24;359(4):391-403
pubmed: 18650515
J Bone Miner Res. 2008 Dec;23(12):2018-24
pubmed: 18684087
J Bone Miner Res. 2015 Sep;30(9):1738-44
pubmed: 25753591
J Bone Miner Res. 2014 Nov;29(11):2504-10
pubmed: 24806578
J Bone Miner Res. 2011 Oct;26(10):2317-37
pubmed: 21812031
J Bone Miner Res. 2013 Dec;28(12):2570-6
pubmed: 23737456
Calcif Tissue Int. 2017 Mar;100(3):278-285
pubmed: 28012105
J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83
pubmed: 26943719
Bone. 2010 Jan;46(1):190-5
pubmed: 19782782
Clin Endocrinol (Oxf). 2012 Aug;77(2):200-6
pubmed: 22288727
Eur J Endocrinol. 2015 Aug;173(2):G1-20
pubmed: 26160136
J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53
pubmed: 27186861
J Bone Miner Res. 2011 Oct;26(10):2358-70
pubmed: 21773992
J Clin Endocrinol Metab. 2012 Dec;97(12):4507-14
pubmed: 23043192
Calcif Tissue Int. 2018 Aug;103(2):151-163
pubmed: 29511787
Best Pract Res Clin Endocrinol Metab. 2018 Dec;32(6):927-939
pubmed: 30665553
Eur J Endocrinol. 2018 Jan;178(1):103-111
pubmed: 29066572
Expert Opin Drug Saf. 2017 May;16(5):617-625
pubmed: 28332412
Eur J Endocrinol. 2019 Jun 1;181(3):P1-P19
pubmed: 31176307
J Laryngol Otol. 2007 Mar;121(3):237-41
pubmed: 17054818
J Bone Miner Res. 2013 Nov;28(11):2277-85
pubmed: 23661265
Endocrinol Metab Clin North Am. 2003 Jun;32(2):483-502
pubmed: 12800542
Eur J Endocrinol. 2002 Feb;146(2):215-22
pubmed: 11834431
Endocrine. 2019 Apr;64(1):176-183
pubmed: 30788669
N Engl J Med. 2000 Dec 21;343(25):1863-75
pubmed: 11117980
Curr Opin Endocrinol Diabetes Obes. 2012 Dec;19(6):435-42
pubmed: 23128574